Holen Sie sich die Stockscreener-App
0.256
0.00%
0.00
Schlusskurs vom Vortag:
$0.256
Offen:
$0.262
24-Stunden-Volumen:
214.66K
Relative Volume:
0.37
Marktkapitalisierung:
$24.33M
Einnahmen:
$1.22M
Nettoeinkommen (Verlust:
$-14.15M
KGV:
-0.9846
EPS:
-0.26
Netto-Cashflow:
$-6.55M
1W Leistung:
+2.24%
1M Leistung:
-14.47%
6M Leistung:
-27.95%
1J Leistung:
-16.29%
1-Tages-Spanne:
$0.2508
$0.262
1-Wochen-Bereich:
$0.242
$0.271
52-Wochen-Spanne:
$0.242
$0.4985
IGC Pharma Inc Stock (IGC) Company Profile
Firmenname
IGC Pharma Inc
Sektor
Branche
Telefon
301-983-0998
Adresse
4336 Montgomery Avenue, Bethesda, MD
Compare IGC vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.256 | 24.33M | 1.22M | -14.15M | -6.55M | -0.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
IGC Pharma Inc Aktie (IGC) Neueste Nachrichten
IGC Pharma to Participate in Fireside Chat With Ascendiant Capital Markets - guardonline.com
Is IGC Pharma Inc. likely to announce a buybackJuly 2025 Market Mood & Daily Entry Point Alerts - mfd.ru
Aug Catalysts: Should I trade or invest in IGC Pharma IncJuly 2025 Intraday Action & Stepwise Swing Trade Plans - baoquankhu1.vn
Why IGC Pharma Inc. (IGS1) stock could rally stronglyJuly 2025 Breakouts & Accurate Entry and Exit Point Alerts - mfd.ru
IGC Pharma Announces Equity Research Update by Alliance Global Partners - BioSpace
IGC Pharma Announces Equity Research Update by Alliance Global P - GuruFocus
IGC Pharma Expands Phase 2 CALMA Trial into Colombia's Premier Alzheimer's Research Center - BioSpace
IGC Pharma Expands Phase 2 CALMA Trial into Colombia's Premier A - GuruFocus
IGC Pharma Expands Key Alzheimer's Trial into Colombia - GuruFocus
Colombia’s unique inherited Alzheimer’s community joins IGC drug trial - Stock Titan
IGC Pharma erweitert Alzheimer-Studie nach Kolumbien - Longbridge
Trade Report: Will IGC Pharma Inc benefit from green energy policiesWall Street Watch & Real-Time Buy Signal Notifications - baoquankhu1.vn
Trend Recap: Can IGC Pharma Inc ride the EV wave2025 Support & Resistance & Daily Profit Maximizing Tips - baoquankhu1.vn
Treasury Yields: Is IGC Pharma Inc in a bullish channelJuly 2025 EndofMonth & Low Drawdown Investment Ideas - baoquankhu1.vn
Retail Trends: Can SUUN sustain earnings growth2025 Macro Impact & Weekly High Return Stock Forecasts - baoquankhu1.vn
Market Pulse: How volatile is ProShares Trust ProShares Short High Yield stockPortfolio Profit Report & Expert-Curated Trade Recommendations - baoquankhu1.vn
IGC Pharma Reaches 70% Enrollment in Phase 2 CALMA Trial Evaluating IGC-AD1 for Alzheimer's Agitation - Weatherford Democrat
Alzheimer’s agitation trial passes 70% enrollment milestone - Stock Titan
Forecast Cut: Is IGC Pharma Inc a cyclical or defensive stockJuly 2025 Outlook & High Return Stock Watch Alerts - baoquankhu1.vn
Setup Watch: Is IGC Pharma Inc a momentum stockJuly 2025 Recap & Real-Time Volume Spike Alerts - baoquankhu1.vn
Aug Breakouts: How does IGC Pharma Inc perform in inflationary periods2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Aug Volume: Should I buy SONY stock nowEarnings Growth Summary & Verified Momentum Stock Ideas - baoquankhu1.vn
IGC Pharma announces registered direct equity offering financing - MSN
IGC Pharma Expands Phase 2 CALMA Trial With New Clinical Trial Site at Integrative Clinical Trials in New York - 富途牛牛
IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Trial Site at Integrative Clinical Trials in New York - Finviz
IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Trial S - GuruFocus
IGC Expands Alzheimer's Clinical Trial with New Site in Brooklyn - GuruFocus
NYC clinic joins trial of cannabinoid drug for Alzheimer's agitation - Stock Titan
Day Trade: Should value investors consider IGC Pharma IncJuly 2025 Reactions & Weekly High Return Opportunities - baoquankhu1.vn
Retail Trends: Whats the MACD signal for Invesco QQQ Trust Series 12025 Market Outlook & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Performance Recap: Is IGC Pharma Inc a cyclical or defensive stockJuly 2025 Update & Real-Time Market Trend Scan - baoquankhu1.vn
Does IGC Pharma Inc stock have upside surprise potentialMarket Risk Summary & Technical Pattern Alert System - baoquankhu1.vn
Weekly Recap: Is IGC Pharma Inc likely to announce a buybackExit Point & Fast Entry High Yield Tips - baoquankhu1.vn
Loss Report: Can IGC Pharma Inc deliver alphaJuly 2025 Retail & AI Enhanced Execution Alerts - baoquankhu1.vn
IGC Pharma aligns fiscal year with calendar year - MSN
IGC Pharma expands Phase 2 CALMA trial with new clinical site - TipRanks
IGC Pharma Expands Alzheimer's Clinical Trial with New Research Site - GuruFocus
IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Site at Dominion Medical Associates, a Lightship Network Site, in Richmond, Virginia - ACCESS Newswire
Whittier Daily News - FinancialContent
Published on: 2026-01-11 01:25:41 - Улправда
IGC Pharma adjusts fiscal year-end to December 31 - MSN
Can IGC Pharma Inc. stock outperform in 2025 bull marketTrade Risk Summary & Capital Protection Trading Alerts - ulpravda.ru
Why IGC Pharma Inc. stock gets analyst attentionQuarterly Performance Summary & Consistent Return Strategy Ideas - Улправда
Will IGC Pharma Inc. stock deliver long term returnsJuly 2025 Selloffs & Advanced Swing Trade Entry Alerts - Улправда
Can IGC Pharma Inc. stock sustain revenue momentum2025 Investor Takeaways & Low Volatility Stock Suggestions - ulpravda.ru
How IGC Pharma Inc. stock reacts to inflationary pressuresMarket Movers & Fast Momentum Entry Tips - ulpravda.ru
Is IGC Pharma Inc. stock attractive after correctionProfit Target & Low Risk High Reward Trade Ideas - Улправда
Does IGC Pharma Inc. (IGS1) stock trade below intrinsic value2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - ulpravda.ru
Will IGC Pharma Inc. stock outperform Dow Jones indexJuly 2025 EndofMonth & High Win Rate Trade Alerts - Улправда
How IGC Pharma Inc. stock benefits from strong dollarSell Signal & Consistent Profit Trade Alerts - ulpravda.ru
Can IGC Pharma Inc. stock double in next 5 yearsWeekly Volume Report & Weekly Top Performers Watchlists - ulpravda.ru
Finanzdaten der IGC Pharma Inc-Aktie (IGC)
Umsatz
Nettogewinn
Free Cashflow
ENV
IGC Pharma Inc-Aktie (IGC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PRINS RICHARD K | Director |
Jan 19 '26 |
Option Exercise |
0.00 |
100,000 |
0 |
1,371,251 |
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):